In vitro affinity of Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis

Nuclear Medicine Communications

Volumn 22, Issue 5, 2001, Pages 553-558

  Dezutter, N A ^a   Sciot, R M ^a   de Groot, T J ^b   Bormans, G M ^b   Verbruggen, A M ^b  

^a Faculty of Pharmaceutical Sciences   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amyloidosis; Autoradiography; Tcm chrysamine G

Indexed keywords

AMYLOID A PROTEIN; CHRYSAMINE G; CONGO RED; DYE; IODINE 123; SERUM AMYLOID P; TECHNETIUM 99M; UNCLASSIFIED DRUG; 99MTC MAMA CHRYSAMINE G; 99MTC-MAMA-CHRYSAMINE G; AMYLOID; BENZOIC ACID DERIVATIVE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM; TECHNETIUM COMPLEX;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTORADIOGRAPHY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; MALE; QUANTITATIVE DIAGNOSIS; SCINTIGRAPHY; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; SCINTISCANNING; SYNTHESIS;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; AUTORADIOGRAPHY; BENZOATES; CHILD; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REFERENCE VALUES; TECHNETIUM;

EID: 0034997884     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200105000-00014     Document Type: Article

References (29)

1. Miller DL, Papayannopoulus IA, Styles J et al. Peptide compositions of cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993; 301: 41-52.
2. Johnson KH, O'Brien TD, Betsholtz C, Westermark P. Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. New Engl J Med 1989; 321: 513-518.
3. Drueke T, Touam M, Zingraff J. Dialysis associated amyloidosis. Adv Ren Replace Ther 1995; 2: 24-39.
4. Linke RP, Heilmann KL, Nathrath WB, Eulitz M. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin fixed tissue. Lab Invest 1983; 48: 698-704.
5. Sletten K, Westermark P, Natvig JB. Characterisation of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 1976; 143: 993-998.
6. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid pre-albumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880-888.
7. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. Purification and structural studies of a major Scrapie prion protein. Cell 1984; 38: 127-134.
8. Beekes M, Baldauf E, Cassens S et al. Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method. J Gen Virol 1995; 76: 2567-2576.
9. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355-364.
10. Kazatchkine MD, Husby G, Araki S et al. Nomenclature of amyloid and amyloidosis-WHO-IUIS nomenclature subcommittee. Bull WHO 1993; 71: 105-108.
11. Röcken C, Schwotzer EB, Linke RP, Saeger W. The classification of amyloid deposits in clinicopathological practice. Histopathology 1996; 29: 325-335.
12. Libby CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med 1983; 143: 1549-1552.
13. Kyle RA, Spencer RJ, Dahlin DC. Value of rectal biopsy in the diagnosis of primary systemic amyloidosis. Am J Med Sci 1966; 251: 501-506.
14. Delgado AW, Mosqueda A. A highly sensitive method for diagnosis of secondary amyloidosis by labial salivary gland biopsy. J Oral Pathol Med 1989; 18: 310-314.
15. Hawkins PN. Diagnosis and monitoring of amyloidosis. Baillières Clin Rheumatol 1994; 8: 635-659.
16. Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis. Eur J Nucl Med 1993; 20: 130-137.
17. Friman C, Pettersson T. Amyloidosis. Curr Opin Rheumatol 1996; 8: 62-71.
18. Pepys MB, Rademacher TW, Amatayakul-Chantler S et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994; 91: 5602-5606.
19. Pepys MB, Dyck RF, De Beer FC, Skinner M, Cohen AS. Binding of serum amyloid-P component (SAP) by amyloid fibrils. Clin Exp Immunol 1979; 38: 284-293.
20. 123I-labelled serum amyloid P component. N Engl J Med 1990; 323: 508-513.
21. Hawkins PN, Pepys MB. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 1995; 22: 595-599.
22. Hawkins PN, Lavender JP, Myers MJ, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988; i: 1413-1418.
23. 2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease. J Labelled Cpd Radiopharm 1999; 42: 309-324.
24. Klunk WE, Debnath ML, Pettegrew JW. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease. Neurobiol Aging 1994; 15: 691-698.
25. m-MAMA-chrysamine G, a potential probe for beta-amyloid protein of Alzheimer's disease. Eur J Nucl Med 1999; 26: 1392-1399.
26. Klunk WE, Pettegrew JW, Abraham DJ. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 1989; 37: 1273-1281.
27. Carter DB, Chou K-C. A model for structure-dependent binding of Congo red to Alzheimer β-amyloid fibrils. Neurobiol Aging 1998; 19: 37-40.
28. Cavillon F, Elhaddaoui A, Alix AJP, Turrell S, Dauchez M. Identification of the importance of the secondary structure of Alzheimer's disease amyloid. J Mol Struct 1997; 408: 185-189.
29. Linke RP, Gärtner HV, Michels H. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits. J Histochem Cytochem 1995; 43: 863-869.